The impact of the HPV vaccine on the world

initial outcomes and challenges

Authors

  • Daniel Vitorino Ribeiro
  • Sérgio Murillo Steffens
  • Edison Natal Fedrizzi

Keywords:

HPV, vaccination, precancerous conditions, cervical cancer, cervical cancer;

Abstract

Introduction: Human papillomavirus (HPV) infection can be considered an epidemic in the world and in Brazil. This infection accounts for virtually all cases of cervical cancer, most malignant anal, vaginal and oropharyngeal tumors, and a large number of cases of cancer of the penis and vulva. The most effective way to prevent this infection is through vaccination. Several countries, including Brazil, have already introduced this vaccine into the public vaccination programs and are observing the real-life results of decreasing HPV-associated diseases. Objective: To evaluate the effectiveness of HPV vaccination in preventing virus-induced diseases in countries that have adopted it for a longer time, in a different scenario from clinical studies. Methods: This is a bibliographic review study in journal databases PubMed, LILACS, SciELO and Scopus, with publications dated from 2000 to 2019. The research was restricted to articles in English and Portuguese and studies conducted in humans. Ten studies that were considered relevant were selected. Furthermore, additional articles found by free search were selected. After this phase, the chosen publications were obtained in full for reassessment of their methodology and results. Results: The HPV vaccine demonstrated its effectiveness in reducing the incidence of HPV infection and/or anogenital warts and/or precancerous lesions in the seven countries analyzed by the study: Australia, Brazil, Denmark, United States of America, New Zealand, Czech Republic and Sweden. The impact was bigger in countries that introduced it earlier, such as Australia, where the vaccine virtually eliminated the incidence of genital warts in women aged under 21 years. Although Brazil implemented the vaccine a few years ago, a preliminary study was conducted in Campos dos Goytacazes, RJ, where the vaccine was implemented in 2010, showing a 55% reduction in the incidence of genital warts for women aged under 21 years old, between 2007 and 2012. Conclusion: The HPV vaccine is highly effective in protecting against HPV infection and disease in the countries where it has been implemented, with better results than those seen in clinical trials.

Downloads

Download data is not yet available.

Author Biographies

Daniel Vitorino Ribeiro

Department of Gynecology and Obstetrics, Universidade Federal de Santa Catarina – Florianópolis (SC), Brazil.

Sérgio Murillo Steffens

Department of Gynecology and Obstetrics, Universidade Federal de Santa Catarina – Florianópolis (SC), Brazil.

Edison Natal Fedrizzi

Department of Gynecology and Obstetrics, Universidade Federal de Santa Catarina – Florianópolis (SC), Brazil. HPV Project Clinical Research Center – Florianópolis (SC), Brazil.

Downloads

Published

2020-12-01

How to Cite

1.
Ribeiro DV, Steffens SM, Fedrizzi EN. The impact of the HPV vaccine on the world: initial outcomes and challenges. DST [Internet]. 2020 Dec. 1 [cited 2024 Mar. 28];32. Available from: https://bjstd.org/revista/article/view/890

Issue

Section

Original Article